Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10202166 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Weekly cisplatin with RT;   Drug: Tri-weekly cisplatin with RT
2 Withdrawn Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Condition: Cervical Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Radiation: Radiation Therapy
3 Terminated Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Cisplatin;   Radiation: Radiation Therapy;   Procedure: Mastectomy

Indicates status has not been verified in more than two years